Phosphodiesterase 7A: A New Therapeutic Target for Alleviating Chronic Inflammation?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|25|3207-3220

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.25, 2006-09, pp. : 3207-3220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation in Atherosclerosis: A New Therapeutic Target

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 8, 2015-10 ,pp. : 1012-1023

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches to Chronic Intestinal Inflammation by Specific Targeting of Mucosal IL-7 / IL-7R Signal Pathway

By  

Current Drug Targets. Inflammation & Allergy, Vol. 2, Iss. 2, 2003-06 ,pp. : 119-123

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrogen sulfide as a therapeutic target for inflammation

By Rivers Jack R   Badiei Alireza   Bhatia Madhav  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 439-449

Informa Healthcare

Access to resources Recommend Favorite